Common Stock Reserved For Issuance

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Common Stock Reserved For Issuance

Note 10.  COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of September 30, 2020		As of December 31, 2019
Shares underlying outstanding stock options		891,748		579,731
Shares available for future stock option grants		208,395		230,952
Exchange of Vaccinex Products, LP units		1,154,935		1,173,500
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,573,875		3,302,980

During the nine months ended September 30, 2020 and 2019, 18,565 and 4,455 units, respectively, of Vaccinex Products, LP were exchanged for shares of the Company’s common stock at par value of $0.0001 per share.